SCHEMBL27747701

SCHEMBL27747701

CS(F)(F)c1cc[c]cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2377334 0.77
SCHEMBL20194 0.72 ENPP2 (0.50)
SCHEMBL1490225 0.72 F2 (0.41)
SCHEMBL17804300 0.71 HTR6 (0.43)
SCHEMBL17290582 0.69 ENPP2 (0.36)
SCHEMBL167548 0.67 SMN1; SMN2 (0.58)
SCHEMBL28108063 0.67 CYP2A6 (0.44)
Water SCHEMBL28104228 0.65
SCHEMBL2120 0.65
SCHEMBL818508 0.65 HTR6 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105985361-B Difluoro methylthiolation reagent, preparation method and applications 中国科学院上海有机化学研究所 2018-02-16 CN disclosed
CN-101039904-B Is suitable for treating dopamine D3Heterocyclic compounds for receptor-modulated responsive disorders ABBOTT GMBH & CO KG 2014-09-24 CN disclosed
CN-102137841-A Ortho-substituted haloalkylsulfonanilide derivative and herbicide NISSAN CHEMICAL IND LTD 2011-07-27 CN disclosed
CN-101421264-A Is suitable for treating serotonin 5HT6Heterocyclic compounds for receptor-modulated responsive disorders ABBOTT GMBH & CO KG (DE) 2009-04-29 CN disclosed